Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,267,721
-
Share change
-
+1,802,185
-
Total reported value
-
$441,635,548
-
Put/Call ratio
-
76%
-
Price per share
-
$8.45
-
Number of holders
-
129
-
Value change
-
+$12,455,598
-
Number of buys
-
62
-
Number of sells
-
73
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q3 2015
As of 30 Sep 2015,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,267,721 shares.
The largest 10 holders included
VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, STATE STREET CORP, BlackRock Fund Advisors, BB BIOTECH AG, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
129
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.